We are evaluating the safety of a new imaging agent for patients with CAIX-positive cancer. This study aims to ensure it is safe for use in future treatments.
Health conditions and diseases that the clinical trial is designed to study and treat.
Clear Cell Renal Cell Carcinoma (ccRCC) is a type of kidney cancer that originates in the lining of the kidney's tubules, often leading to symptoms such as blood in urine, persistent back pain, and unexplained weight loss.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.